Longitudinal persistence with secondary prevention therapies relative to patient risk after myocardial infarction

Abstract

High-risk patients with AMI have a lower likelihood of persistently taking prescribed medications post discharge as compared with low-risk patients. Continued efforts are needed to improve the use of guideline-directed medications in high-risk patients.